Stereotactic Surgery Devices Market Report 2026

Stereotactic Surgery Devices Market Overview

• Stereotactic Surgery Devices market size has reached to $22.44 billion in 2025 • Expected to grow to $30.94 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Stereotactic Surgical Devices Surge In Demand Amidst Rising Parkinson's Disease And Epilepsy Cases • Market Trend: Advancements In Surface-Guided Tracking Technology Improve Precision And Treatment Accuracy In Stereotactic Procedures • North America was the largest region in 2025.

What Is Covered Under Stereotactic Surgery Devices Market?

A stereotactic surgical device is a technology that employs a set of three coordinates to precisely locate brain parts while the head is in a fixed position. It is used in stereotactic surgery to implant things into the brain, such as medications or hormones. The stereotactic surgical devices market research report is one of a series of new reports from The Business Research Company that provides stereotactic surgical devices market statistics, including stereotactic surgical devices industry global market size, regional shares, competitors with a stereotactic surgical devices market share, detailed stereotactic surgical devices market segments, market trends, and opportunities, and any further data you may need to thrive in the stereotactic surgical devices industry. The stereotactic surgical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

What Is The Stereotactic Surgery Devices Market Growth Forecast?

The stereotactic surgery devices market size is expected to see strong growth in the next few years. It will grow to $30.94 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for precision neurosurgery, rising investments in advanced radiosurgery platforms, expansion of AI-assisted surgical planning, growing adoption of non-invasive treatment methods, increasing focus on patient-specific therapy. Major trends in the forecast period include increasing adoption of image-guided stereotactic systems, rising use of robotic-assisted neurosurgical platforms, growing integration of high-precision navigation technologies, expansion of non-invasive radiosurgery solutions, enhanced focus on treatment accuracy and safety.

Global Stereotactic Surgery Devices Market Segmentation

1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, CyberKnife 2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications 3) By End User: Hospitals, Specialty Neurosurgical Centers, Cancer Treatment Centers, Academic And Research Medical Centers Subsegments: 1) By Gamma Knife: Leksell Gamma Knife Perfexion, Leksell Gamma Knife Icon 2) By Line Accelerator (LINAC) Machines: Conventional LINAC, Image-Guided Radiation Therapy (IGRT) LINAC 3) By CyberKnife: CyberKnife M6 System, CyberKnife VSI System

What Are The Drivers Of The Stereotactic Surgery Devices Market?

The increasing number of Parkinson's disease and epilepsy are expected to boost the growth of the stereotactic surgical device market going forward. Parkinson's disease is a neurodegenerative illness that causes involuntary shaking, sluggish movement, and stiff, inflexible muscles, whereas epilepsy is a neurological ailment that affects the brain and renders patients more susceptible to experiencing recurring, unprovoked seizures. Stereotactic surgical devices are used to treat movement disorders, epilepsy, pain, and psychiatry, as well as Parkinson's disease. For instance, in November 2024, according to the British Psychological Society, a UK-based representative body for psychology, across Wales, an estimated 100,000 people live with long-term neurological conditions, including more than 41,000 affected by disorders such as Parkinson’s disease, epilepsy, multiple sclerosis, muscular dystrophy, motor neurone disease, and cerebral palsy, while each year approximately 2,500 additional cases of Parkinson’s disease, epilepsy, multiple sclerosis, or motor neurone disease are diagnosed. Therefore, increasing cases of Parkinson's disease and epilepsy are driving the growth of the stereotactic surgical device market. The growing geriatric population are expected to boost the growth of the stereotactic surgical device market going forward. The geriatric population refers to elderly individuals, typically defined as those aged 65 and older. Stereotactic surgical devices play a crucial role in providing minimally invasive and precise treatment options for the geriatric population, addressing the unique health challenges faced by this demographic group. For instance, in October 2025, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, by 2030, one in six people globally will be aged 60 or older, with the population of individuals in this age group projected to double to 2.1 billion by 2050. Therefore, growing geriatric population drives the stereotactic surgical device market.

Key Players In The Global Stereotactic Surgery Devices Market

Major companies operating in the stereotactic surgery devices market are Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, Ion Beam Applications S.A., ZAP Surgical Systems Inc., Brainlab AG, Monteris Medical Holding AG, Renishaw plc, Medtronic plc, Nexstim Plc, FHC Inc., Alpha Omega Engineering Inc., Mitsubishi Heavy Industries Ltd., Inomed Medizintechnik GmbH, MRI Interventions Inc., Modus Medical Devices Inc., Scopis GmbH, Neuropace Inc., Adeor Medical AG, Huiheng Group Co Ltd

Global Stereotactic Surgery Devices Market Trends and Insights

Major companies operating in the stereotactic surgical device market are focusing on developing advanced tracking and positioning technologies to enhance procedural accuracy, patient safety, and treatment outcomes. These innovations aim to provide high-precision localization, real-time monitoring, and greater workflow efficiency during stereotactic interventions, including radiosurgery and body radiation therapy. For instance, in May 2023, Brainlab, a Germany-based medical technology company, introduced ExacTrac Dynamic Surface, a next-generation surface-guided radiation therapy (SGRT) patient tracking and positioning system. The solution integrates high-speed thermal surface tracking with enhanced ExacTrac X-ray monitoring, enabling more versatile and accurate patient alignment for cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system projects a structured blue light pattern onto the patient, captured by two 3D cameras, while an additional in-unit camera records thermal signatures, allowing each surface point to be precisely registered. This technological advancement supports more reliable and controlled stereotactic treatment delivery.

Regional Outlook

North America was the largest region in the stereotactic surgery devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Stereotactic Surgery Devices Market?

The stereotactic surgical device market consists of sales of intracranial drilling, intracranial injections, and brain cannulation. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.